Welcome
M. MassaiaSESSION I
Passive immunotherapy I: novel targets and therapeutics
SESSION II
Passive immunotherapy II: bispecific & antibody-drug conjugates
SESSION III
Adoptive immunotherapy I: CAR-T cells
LECTURE II
SESSION IV
Adoptive immunotherapy II: CAR-T cells and beyond
SESSION V
Tools & strategies to improve the efficacy of immunotherapy
Mechanisms of resistance to CAR-T cell therapy
F. SimonettaClinical application of artificial intelligence in hematology
M.G. Della PortaLECTURE III
SESSION VI
From tumor vaccination to oncolytic immunotherapy and engineered bacteria: back to the future
LECTURE IV
Multiplex base editing to generate CAR-T cells
D.T. TeacheyLECTURE V
Introduction
F. Di RaimondoSESSION VII
Immune lessons from allo-HSCT